Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Current Treatment Options in Oncology
|
August 23, 2021
Immunotherapy in Hepatocellular Carcinoma
Claudia A M Fulgenzi, Thomas Talbot, Sam M Murray, et al.
Chemotherapy
|
January 9, 2022
New Frontiers in the Medical Therapy of Hepatocellular Carcinoma
Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Thomas Talbot, et al.
Expert Review of Molecular Diagnostics
|
March 3, 2022
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma
Ambreen Muhammed, Antonio D'Alessio, Andrei Enica, et al.
Critical Care (London, England)
|
February 7, 2025
Physiology and pathophysiology of mucus and mucolytic use in critically ill patients
Thomas Roe, Thomas Talbot, Isis Terrington, et al.
Studies in Health Technology and Informatics
|
April 16, 2014
Expansion of a VR Exposure Therapy System for Combat-Related PTSD to Medics/Corpsman and Persons Following Military Sexual Trauma
Albert Rizzo, Arno Hartholt, Barbara Rothbaum, et al.
Journal of Gastrointestinal Oncology
|
November 16, 2023
Overall survival and treatment modalities in pancreatic adenocarcinoma: a retrospective analysis of a single centre in Western Australia
Alice Talbot, Thomas Talbot, Emma Shaughnessy, et al.
Developmental Biology
|
August 26, 2006
Genetic interactions between Drosophila melanogaster menin and Jun/Fos
Aniello Cerrato, Michael Parisi, Sonia Santa Anna, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 2, 2026
Identifying barriers to Hepatitis C virus elimination in the era of direct-acting antivirals
Thomas Talbot, Gillian Farrell, Catherine Murray, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 28, 2022
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study
Thomas Talbot, Antonio D'Alessio, Matthias Pinter, et al.
Cell Reports. Medicine
|
April 1, 2025
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors
Ruth Plummer, Mikael H Sodergren, Rose Hodgson, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Current Treatment Options in Oncology
|
August 23, 2021
Immunotherapy in Hepatocellular Carcinoma
Claudia A M Fulgenzi, Thomas Talbot, Sam M Murray, et al.
Chemotherapy
|
January 9, 2022
New Frontiers in the Medical Therapy of Hepatocellular Carcinoma
Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Thomas Talbot, et al.
Expert Review of Molecular Diagnostics
|
March 3, 2022
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma
Ambreen Muhammed, Antonio D'Alessio, Andrei Enica, et al.
Critical Care (London, England)
|
February 7, 2025
Physiology and pathophysiology of mucus and mucolytic use in critically ill patients
Thomas Roe, Thomas Talbot, Isis Terrington, et al.
Studies in Health Technology and Informatics
|
April 16, 2014
Expansion of a VR Exposure Therapy System for Combat-Related PTSD to Medics/Corpsman and Persons Following Military Sexual Trauma
Albert Rizzo, Arno Hartholt, Barbara Rothbaum, et al.
Journal of Gastrointestinal Oncology
|
November 16, 2023
Overall survival and treatment modalities in pancreatic adenocarcinoma: a retrospective analysis of a single centre in Western Australia
Alice Talbot, Thomas Talbot, Emma Shaughnessy, et al.
Developmental Biology
|
August 26, 2006
Genetic interactions between Drosophila melanogaster menin and Jun/Fos
Aniello Cerrato, Michael Parisi, Sonia Santa Anna, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 2, 2026
Identifying barriers to Hepatitis C virus elimination in the era of direct-acting antivirals
Thomas Talbot, Gillian Farrell, Catherine Murray, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 28, 2022
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study
Thomas Talbot, Antonio D'Alessio, Matthias Pinter, et al.
Cell Reports. Medicine
|
April 1, 2025
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors
Ruth Plummer, Mikael H Sodergren, Rose Hodgson, et al.
Page
of 3